KRAS is one of the most frequently mutated oncogenes in human cancers, playing a critical role in tumor initiation, progression, and therapeutic resistance. Mutations such as KRAS G12C, G12D, G12V, and G13D are commonly observed in lung, colorectal, and pancreatic cancers, making KRAS a high-value but historically challenging drug target. TargetMol provides KRAS-related products, including a comprehensive range of small-molecule inhibitors, biochemical tools, and research reagents designed to ...
The Gibco Expi293 PRO Expression System is a complete solution for rapid, high-yield protein production from HEK293 cells. It is a fully integrated expression system designed to deliver higher yields of a wider variety of proteins—including challenging and low-yield proteins—with exceptional speed, efficiency, and an easy-to-automate protocol. Producing increasingly complex proteins with higher yields and increased throughput is critical to accelerating breakthroughs in protein research ...